Components of

Rabies Vaccines

Components Page
Excipients Table
Allergens Table
       
Name Imovax RabAvert
Manufacturer sanofi pasteur GlaxoSmithKline
Viability Inactivated Inactivated
Indicated Ages All age groups All age groups
Dose 1.0 mL 1.0 mL
Schedule Pre-exposure: 3 dose series on days 0, 7 and 21 or 28 Pre-exposure: 3 dose series on days 0, 7 and 21 or 28
Route Intramuscular Intramuscular
Appearance Creamy white to orange; after reconstitution pink to red Clear to slightly opalescent, colorless to slightly pink
Concentration Rabies antigen, 2.5 IU Rabies antigen, ≥ 2.5 IU
Preservative None None
Adjuvant None None
Excipients • Human albumin, < 100 mg
• Neomycin sulfate, < 150 mcg
• Phenol red indicator, 20 mcg
• Beta-propiolactone, < 50 ppm
• Polygeline (processed bovin gelatin, ≤ 12 mg
• Human serum albumin, ≤ 0.3 mg
• Potassium glutamate, 1 mg
• Sodium EDTA, 0.3 mg
• Bovine serum, "small quantities"
• Ovalbumin, ≤ 3 ng
• Neomycin, ≤ 10 mcg
• Chlortetracycline, ≤ 200 ng
• Amphotericin B, ≤ 20 ng
• Chicken fibroblasts, Amount not specified
• Beta-propiolactone, Amount not specified
Allergens • Albumin, < 50 ng
• Neomycin, < 5 ng
• Polymyxin B, 25 ng
• Streptomycin, 200 ng
• Bovine albumin, "small quantities"
• Ovalbumin, ≤ 3 ng
• Amphotericin B, < 20 mg
• Chlortetracyclin, ≤ 200 ng
• Bovine gelatin, < 12 mg polygeline
• Neomycin, < 10 mcg
Media MRC-5 strain human diploid cells Synthetic cell culture medium with additional human albumin, polygeline and antibiotics
Packaging Single-dose vial Single-dose kit (vial+syringe for reconstitution+needles)
Storage 2-8C (35-46F)
Do not freeze
2-8C (35-46F)
Do not freeze
PI date Apr 2013 Aug 2018
    table last updated 12/27/18